JPH06145037A - Skin external preparation - Google Patents
Skin external preparationInfo
- Publication number
- JPH06145037A JPH06145037A JP16208292A JP16208292A JPH06145037A JP H06145037 A JPH06145037 A JP H06145037A JP 16208292 A JP16208292 A JP 16208292A JP 16208292 A JP16208292 A JP 16208292A JP H06145037 A JPH06145037 A JP H06145037A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- external preparation
- amino acids
- present
- skin external
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 21
- 150000001413 amino acids Chemical class 0.000 claims abstract description 17
- 239000004202 carbamide Substances 0.000 claims abstract description 11
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 10
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 10
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 10
- 150000003862 amino acid derivatives Chemical class 0.000 claims description 5
- 235000001014 amino acid Nutrition 0.000 abstract description 16
- -1 glycine or serine) Chemical class 0.000 abstract description 10
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract description 4
- 235000003704 aspartic acid Nutrition 0.000 abstract description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 abstract description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 abstract description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract description 2
- 239000004475 Arginine Substances 0.000 abstract description 2
- 108010024636 Glutathione Proteins 0.000 abstract description 2
- 239000004471 Glycine Substances 0.000 abstract description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract description 2
- 239000004472 Lysine Substances 0.000 abstract description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract description 2
- 230000002378 acidificating effect Effects 0.000 abstract description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 abstract description 2
- 229960003180 glutathione Drugs 0.000 abstract description 2
- 206010043268 Tension Diseases 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 229940024606 amino acid Drugs 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 9
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 7
- 239000003518 caustics Substances 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- 229910052700 potassium Inorganic materials 0.000 description 7
- 239000011591 potassium Substances 0.000 description 7
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 6
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 6
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 6
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 229940055577 oleyl alcohol Drugs 0.000 description 6
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 6
- 229940058015 1,3-butylene glycol Drugs 0.000 description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
- 229940082500 cetostearyl alcohol Drugs 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 235000013922 glutamic acid Nutrition 0.000 description 4
- 239000004220 glutamic acid Substances 0.000 description 4
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 4
- 229940099259 vaseline Drugs 0.000 description 4
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000001540 sodium lactate Substances 0.000 description 3
- 235000011088 sodium lactate Nutrition 0.000 description 3
- 229940005581 sodium lactate Drugs 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 2
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 239000004373 Pullulan Substances 0.000 description 2
- 229920001218 Pullulan Polymers 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000019423 pullulan Nutrition 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 2
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- 150000000782 D-glucoses Chemical class 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N N-methylaminoacetic acid Natural products C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000008341 cosmetic lotion Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000008729 phenylalanine Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000008521 threonine Nutrition 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 235000002374 tyrosine Nutrition 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000014393 valine Nutrition 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は皮膚に適度の「潤い」と
「はり」を与える作用を有する安定性に優れる皮膚外用
剤を提供するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention provides an external preparation for skin having excellent stability, which has the effects of imparting proper "moisturization" and "swelling" to the skin.
【0002】[0002]
【従来の技術】一般に、皮膚角質層の水分が、10〜15%
を含んだ状態が健康な皮膚と言われる。水分を含みすぎ
るとフヤケ状態となったり、少なすぎるとカサカサした
状態になったりするので、これを解決するため、化粧
水、クリーム及び乳液等の皮膚外用剤が使われている。
これ等皮膚外用剤中には保湿剤例えば乳酸ナトリウムの
ような有機酸類や、グリセリン、1,3 −ブチレングリコ
ール、プロピレングリコール等が皮膚に対する親和性、
使用感の点から比較的多量(3〜10%)に用いられる。
また、老化や硬化した表皮に水和性を回復することを期
待してアミノ酸、尿素が用いられている。2. Description of the Related Art Generally, the water content of stratum corneum is 10 to 15%.
It is said that the condition containing is healthy skin. If it contains too much water, it becomes dull, and if it is too small, it becomes dull, so in order to solve this, external skin preparations such as lotion, cream and emulsion are used.
In these external preparations for skin, moisturizing agents such as organic acids such as sodium lactate, glycerin, 1,3-butylene glycol, propylene glycol and the like have an affinity for the skin,
It is used in a relatively large amount (3-10%) from the point of use.
In addition, amino acids and urea are used in the hope that they will restore hydration to the aged and hardened epidermis.
【0003】[0003]
【発明が解決しようとする課題】しかしながら、特にリ
ッチ感を訴求する皮膚外用剤においては、上記の保湿剤
を極めて多量に配合する傾向にあり、そのために皮膚に
対するベタツキ感が生じていた。また、これら保湿剤配
合の皮膚外用剤を低湿度下で使用すると外気湿度が少な
いことから、皮膚中から保湿剤配合の皮膚外用剤へと逆
に水分がとり込まれ、皮膚を乾燥せしめてしまう場合も
あった。一方、アミノ酸を配合した皮膚外用剤は上記保
湿剤を配合した場合のような欠点はないものの、経時に
よる変臭が問題となっていた。又、尿素は、匂いのみな
らず経日安定性に問題がある。However, especially in the external preparation for skin which appeals a rich feeling, there is a tendency that the above moisturizer is blended in an extremely large amount, which causes a sticky feeling on the skin. In addition, when these skin external preparations containing moisturizers are used under low humidity, the humidity of the outside air is low, so water is absorbed from the skin to the skin external preparations containing moisturizers, which causes the skin to dry. In some cases. On the other hand, the skin external preparation containing an amino acid does not have the drawbacks as in the case of adding the above moisturizing agent, but has a problem of odor change over time. Urea has a problem not only in smell but also in stability over time.
【0004】[0004]
【課題を解決するための手段】本発明者等は、上記事情
に鑑み、鋭意研究を重ねた結果、アミノ酸、アミノ酸の
誘導体及び尿素からなる群から選ばれる一種又は二種以
上と、トレハロースとを配合した皮膚外用剤は、安定性
に優れ、皮膚に適度の「潤い」と「はり」を与えると共
に、使用感を著しく改善する効果に優れることを見出
し、本発明を完成するに至った。すなわち本発明は、ア
ミノ酸、アミノ酸の誘導体及び尿素からなる群から選ば
れる一種又は二種以上と、トレハロースとを配合するこ
とを特徴とする皮膚外用剤を提供するものである。Means for Solving the Problems In view of the above circumstances, the present inventors have conducted extensive studies and as a result, have found that trehalose and one or more selected from the group consisting of amino acids, amino acid derivatives and urea. It has been found that the compounded external preparation for skin is excellent in stability, gives proper "moisturization" and "swelling" to the skin, and is also excellent in the effect of remarkably improving the feeling of use, and thus completed the present invention. That is, the present invention provides an external preparation for skin, which comprises trehalose and one or more selected from the group consisting of amino acids, amino acid derivatives and urea.
【0005】以下、本発明の構成について詳述する。本
発明に用いられるアミノ酸とは、グリシン、セリン、シ
スチン、アラニン、トレオニン、システイン、バリン、
フェニルアラニン、メチオニン、ロイシン、チロシン、
プロリン、イソロイシン、トリプトファン、ヒドロキシ
プロリン等の中性アミノ酸、アスパラギン酸、アスパラ
ギン、グルタミン、グルタミン酸等の酸性アミノ酸、ア
ルギニン、ヒスチジン、リジン等の塩基性アミノ酸があ
げられる。また、アミノ酸誘導体とはアシルサルコシン
およびその塩、アシルグルダミン酸およびその塩、アシ
ル−β−アラニンおよびその塩、グルタチオン、ピロリ
ドンカルボン酸およびその塩等のほかに、グルタチン、
カルノシン、グラムシギンS、チロシジンA、チロシジ
ンB等のオリゴペプチドが挙げられる。尿素は、一般に
化粧品に用いられるものである。本発明の皮膚外用剤に
はこれらのうち、一種又は二種以上が適宜選択され配合
される。The structure of the present invention will be described in detail below. Amino acids used in the present invention include glycine, serine, cystine, alanine, threonine, cysteine, valine,
Phenylalanine, methionine, leucine, tyrosine,
Examples thereof include neutral amino acids such as proline, isoleucine, tryptophan and hydroxyproline, acidic amino acids such as aspartic acid, asparagine, glutamine and glutamic acid, and basic amino acids such as arginine, histidine and lysine. Further, the amino acid derivative, acyl sarcosine and a salt thereof, acyl glutamic acid and a salt thereof, acyl-β-alanine and a salt thereof, glutathione, pyrrolidone carboxylic acid and a salt thereof, and the like, glutatin,
Examples include oligopeptides such as carnosine, gramcygin S, tyrosidine A, and tyrosidine B. Urea is generally used in cosmetics. The external preparation for skin of the present invention is appropriately selected and blended with one or more of these.
【0006】本発明に用いられるアミノ酸、アミノ酸誘
導体又は尿素の配合量は、本発明の皮膚外用剤中、0.01
〜30重量%、好ましくは、0.05〜20重量%である。配合
量が0.01%未満では皮膚に対する保湿効果が弱く、逆に
30%以上加えても効果の増加は実質上望めないし、尿
素、アミノ酸の経日安定性を向上させにくくなる傾向に
ある。The amount of the amino acid, amino acid derivative or urea used in the present invention is 0.01% in the skin external preparation of the present invention.
-30% by weight, preferably 0.05-20% by weight. If the blending amount is less than 0.01%, the moisturizing effect on the skin is weak, and conversely
Even if it is added in an amount of 30% or more, the effect cannot be expected to increase, and it tends to be difficult to improve the daily stability of urea and amino acids.
【0007】本発明に係るトレハロースは、D−グルコ
ースが2つ結合した形の2糖類であり、その結合様式は
α,α−、α,β−、β,β−の3種があり、天然に、
多く存在が認められるα,α−の結合様式のものが一般
的である。The trehalose according to the present invention is a disaccharide in which two D-glucoses are bound, and there are three binding modes, α, α-, α, β-, β, β-, which are natural. To
The α, α-bonding mode, which is widely recognized, is common.
【0008】本発明に用いられるトレハロースの配合量
は、皮膚外用剤全量中の0.01〜30重量%であり、好まし
くは0.05〜20重量%である。The amount of trehalose used in the present invention is 0.01 to 30% by weight, preferably 0.05 to 20% by weight, based on the total amount of the external preparation for skin.
【0009】本発明の皮膚外用剤には上記の必須構成成
分に加えて、必要に応じて、通常医薬品、化粧品等の皮
膚外用剤に用いられるその他の成分、例えばエデト酸、
二、三又は四ナトリウム、クエン酸ナトリウム、メタリ
ン酸ナトリウム等の金属イオン封鎖剤、ブチルヒドロキ
シトルエン(BHT)、没食子酸プロピル、トコフェロ
ール等の酸化防止剤、界面活性剤、紫外線吸収剤、香
料、水、エタノール、イソプロパノール等の低級アルコ
ール類、増粘剤、色剤、粉末、薬剤、クエン酸、リンゴ
酸等の有機酸、リン酸等の無機酸等を配合することがで
きる。当然のことながら、これらの成分は本発明の効果
を損なわない質的量的範囲内で用いられなければならな
い。In addition to the above-mentioned essential constituents, the external preparation for skin of the present invention may optionally contain other components usually used in external preparations for skin such as pharmaceuticals and cosmetics, such as edetic acid,
Sequestering agents such as di-, tri- or tetra-sodium, sodium citrate and sodium metaphosphate, butyl hydroxytoluene (BHT), propyl gallate, tocopherol and other antioxidants, surfactants, UV absorbers, fragrances, water , Lower alcohols such as ethanol and isopropanol, thickeners, colorants, powders, drugs, organic acids such as citric acid and malic acid, and inorganic acids such as phosphoric acid. Of course, these components must be used within a qualitative and quantitative range that does not impair the effects of the present invention.
【0010】本発明の皮膚外用剤の剤型は任意であり、
溶液系、可溶化系、乳化系、粉末分散系、水−二層系、
水−油−粉末三層系等、どのような剤型でも構わない。
また、本発明の皮膚外用剤の用途も任意であり、化粧
水、乳液、クリーム、パック等のフェーシャルおよびボ
ディ用皮膚外用剤に用いることができる。The dosage form of the external preparation for skin of the present invention is arbitrary,
Solution system, solubilization system, emulsion system, powder dispersion system, water-two-layer system,
Any formulation such as water-oil-powder three-layer system may be used.
Further, the application of the external preparation for skin of the present invention is also arbitrary, and it can be used for external preparations for facial and body such as lotion, emulsion, cream and pack.
【0011】[0011]
【発明の効果】本発明の皮膚外用剤は、安定性に優れ、
皮膚に適度の「潤い」と「はり」を与えると共に、使用
感を著しく改善した皮膚外用剤である。The external preparation for skin of the present invention has excellent stability,
It is an external preparation for the skin, which imparts proper "moisturization" and "swelling" to the skin and remarkably improves the feeling of use.
【0012】[0012]
【実施例】つぎに実施例および比較例をあげて、本発明
を具体的に明らかにする。本発明はこれにより限定され
るものではない。配合量は重量%である。EXAMPLES Next, the present invention will be specifically described with reference to Examples and Comparative Examples. The present invention is not limited to this. The blending amount is% by weight.
【0013】実施例1 化粧水 次の処方に従い、常法により化粧水を製造した。 エタノール 8.0 1,3 −ブチレングリコール 5.0 ポリオキシエチレン(20モル)オレイルアルコールエーテル 1.8 トレハロース 0.1 ピロリドンカルボン酸ナトリウム 0.5 プルラン 0.05 ホホバ油 0.5 苛性カリ 0.015 EDTA−3Na 0.01 香料 0.1 イオン交換水 残量Example 1 Lotion A lotion was prepared by a conventional method according to the following formulation. Ethanol 8.0 1,3-Butylene glycol 5.0 Polyoxyethylene (20 mol) Oleyl alcohol ether 1.8 Trehalose 0.1 Sodium pyrrolidonecarboxylate 0.5 Pullulan 0.05 Jojoba oil 0.5 Caustic potassium 0.015 EDTA-3Na 0.01 Fragrance 0.1 Deionized water remaining
【0014】実施例2 クリーム 次の処方に従い、常法によりクリームを製造した。 1,3 −ブチレングリコール 3.0 ポリエチレングリコール4000 1.0 グリセリン 2.0 スクワラン 20.0 ワセリン 5.0 セトステアリルアルコール 3.0 ポリオキシエチレン(20モル)オレイルアルコールエーテル 1.5 グリセリールモノステアレート 1.5 トレハロース 20.0 尿素 3.0 乳酸ソーダ 2.0 キサンタンガム(ケルトロール商品名) 0.05 メチルパラベン 0.1 エチルパラベン 0.2 苛性カリ 0.01 EDTA−3Na 0.01 香料 0.2 イオン交換水 残量Example 2 Cream A cream was produced by a conventional method according to the following formulation. 1,3-Butylene glycol 3.0 Polyethylene glycol 4000 1.0 Glycerin 2.0 Squalane 20.0 Vaseline 5.0 Cetostearyl alcohol 3.0 Polyoxyethylene (20 mol) Oleyl alcohol ether 1.5 Glyceryl monostearate 1.5 Trehalose 20.0 Urea 3.0 Sodium lactate 2.0 Xanthan gum (Keltrol product Name) 0.05 Methylparaben 0.1 Ethylparaben 0.2 Caustic potassium 0.01 EDTA-3Na 0.01 Perfume 0.2 Ion-exchanged water Remaining amount
【0015】実施例3 乳液 次の処方に従い、常法により乳液を製造した。 グリセリン 2.0 スクワラン 5.0 ワセリン 1.0 セトステアリルアルコール 0.3 ポリオキシエチレン(20モル)オレイルアルコールエーテル 1.5 グリセリールモノオレート 1.5 トレハロース 10.0 ポリアクリル酸ナトリウム 0.03 エチルパラベン 0.2 アスパラギン酸 10.0 苛性カリ 0.1 EDTA−3Na 0.03 香料 0.2 イオン交換水 残量Example 3 Emulsion An emulsion was prepared by a conventional method according to the following formulation. Glycerin 2.0 Squalane 5.0 Vaseline 1.0 Cetostearyl alcohol 0.3 Polyoxyethylene (20 mol) Oleyl alcohol ether 1.5 Glyceryl monooleate 1.5 Trehalose 10.0 Sodium polyacrylate 0.03 Ethylparaben 0.2 Aspartic acid 10.0 Caustic potassium 0.1 EDTA-3Na 0.03 Perfume 0.2 Deionized water Remaining amount
【0016】実施例4 パック 次の処方に従い、常法によりパックを製造した。 ポリエチレングリコール4000 3.0 エタノール 10.0 トレハロース 15.0 ポリビニルアルコール 10.0 オリーブ油 3.0 乳酸 1.0 グルタミン酸 10.0 カルボキシメチルセルロース 0.07 メチルパラベン 0.1 エチルパラベン 0.1 苛性カリ 0.02 EDTA−3Na 0.01 香料 0.1 イオン交換水 残量Example 4 Pack A pack was manufactured by a conventional method according to the following formulation. Polyethylene glycol 4000 3.0 Ethanol 10.0 Trehalose 15.0 Polyvinyl alcohol 10.0 Olive oil 3.0 Lactic acid 1.0 Glutamic acid 10.0 Carboxymethylcellulose 0.07 Methylparaben 0.1 Ethylparaben 0.1 Caustic potassium 0.02 EDTA-3Na 0.01 Fragrance 0.1 Ion-exchanged water Remaining amount
【0017】比較例1 化粧水 実施例1と同様に製造した。 エタノール 8.0 1,3 −ブチレングリコール 5.0 ポリオキシエチレングリコール 5.0 ポリオキシエチレン(20モル)オレイルアルコールエーテル 1.8 ピロリドンカルボン酸ナトリウム 0.5 プルラン 0.05 ホホバ油 0.5 苛性カリ 0.015 EDTA−3Na 0.01 香料 0.1 イオン交換水 残量Comparative Example 1 Lotion A cosmetic lotion was prepared in the same manner as in Example 1. Ethanol 8.0 1,3-Butylene glycol 5.0 Polyoxyethylene glycol 5.0 Polyoxyethylene (20 mol) Oleyl alcohol ether 1.8 Sodium pyrrolidonecarboxylate 0.5 Pullulan 0.05 Jojoba oil 0.5 Caustic potassium 0.015 EDTA-3Na 0.01 Perfume 0.1 Deionized water remaining amount
【0018】比較例2 クリーム 実施例2と同様に製造した。 1,3 −ブチレングリコール 3.0 ポリエチレングリコール4000 1.0 グリセリン 2.0 スクワラン 20.0 ワセリン 5.0 セトステアリルアルコール 3.0 ポリオキシエチレン(20モル)オレイルアルコールエーテル 1.5 グリセリールモノステアレート 1.5 尿素 3.0 乳酸ソーダ 2.0 キサンタンガム 0.05 メチルパラベン 0.1 エチルパラベン 0.2 苛性カリ 0.01 EDTA−3Na 0.01 香料 0.2 イオン交換水 残量Comparative Example 2 Cream A cream was prepared in the same manner as in Example 2. 1,3-Butylene glycol 3.0 Polyethylene glycol 4000 1.0 Glycerin 2.0 Squalane 20.0 Vaseline 5.0 Cetostearyl alcohol 3.0 Polyoxyethylene (20 mol) Oleyl alcohol ether 1.5 Glyceryl monostearate 1.5 Urea 3.0 Sodium lactate 2.0 Xanthan gum 0.05 Methylparaben 0.1 Ethylparaben 0.2 Caustic potash 0.01 EDTA-3Na 0.01 Fragrance 0.2 Ion-exchanged water Remaining amount
【0019】比較例3 乳液 実施例3と同様に製造した。 グリセリン 2.0 スクワラン 5.0 ワセリン 1.0 セトステアリルアルコール 0.3 ポリオキシエチレン(20モル)オレイルアルコールエーテル 1.5 グリセリールモノオレート 1.5 ポリアクリル酸ナトリウム 0.03 エチルパラベン 0.2 アスパラギン酸 10.0 苛性カリ 0.1 EDTA−3Na 0.03 香料 0.2 イオン交換水 残量Comparative Example 3 Emulsion The same procedure as in Example 3 was repeated. Glycerin 2.0 Squalane 5.0 Vaseline 1.0 Cetostearyl alcohol 0.3 Polyoxyethylene (20 mol) Oleyl alcohol ether 1.5 Glyceryl monooleate 1.5 Sodium polyacrylate 0.03 Ethylparaben 0.2 Aspartic acid 10.0 Caustic potassium 0.1 EDTA-3Na 0.03 Perfume 0.2 Deionized water remaining
【0020】比較例4 パック 実施例4と同様に製造した。 ポリエチレングリコール4000 3.0 エタノール 10.0 ポリビニルアルコール 10.0 オリーブ油 3.0 乳酸 1.0 グルタミン酸 10.0 カルボキシメチルセルロース 0.07 メチルパラベン 0.1 エチルパラベン 0.1 苛性カリ 0.02 EDTA−3Na 0.01 香料 0.1 イオン交換水 残量Comparative Example 4 Pack A pack was prepared as in Example 4. Polyethylene glycol 4000 3.0 Ethanol 10.0 Polyvinyl alcohol 10.0 Olive oil 3.0 Lactic acid 1.0 Glutamic acid 10.0 Carboxymethylcellulose 0.07 Methylparaben 0.1 Ethylparaben 0.1 Caustic potassium 0.02 EDTA-3Na 0.01 Perfume 0.1 Ion-exchanged water Remaining amount
【0021】本発明に係る皮膚外用剤の作用効果を、使
用テストにより確認した。使用テストは、30名の女性を
各3群に分けパネルとした。第1群には実施例1と比較
例1の化粧水を、第2群には実施例2と比較例2のクリ
ームを、第3群には実施例3と比較例3の化粧水を、そ
れぞれ毎日朝と夜の2回、洗顔後顔面の右半分、左半分
に各々実施例、比較例の製剤を適量2週間にわたって塗
布させ、肌の潤い、肌のハリ、翌朝の肌の潤いの3項目
につきその有効性を判定した。結果は表1〜表3に示す
とおりである。安定性については1週間後の匂い、及び
着色を判定した。判定は 極めて良好・・・・・・・・◎ 良好・・・・・・・・・・・○ やや不安定・・・・・・・・△ 不安定・・・・・・・・・・× で表記した。The effect of the external preparation for skin according to the present invention was confirmed by a use test. In the use test, 30 women were divided into 3 groups, and each panel was used. The first group contains the lotions of Example 1 and Comparative Example 1, the second group contains the creams of Example 2 and Comparative Example 2, and the third group contains the lotions of Example 3 and Comparative Example 3. Apply the formulations of Examples and Comparative Examples to the right and left halves of the face after washing twice daily in the morning and evening, respectively, for a suitable amount of 2 weeks, and moisturize the skin, firm the skin, and moisturize the next morning. The effectiveness of each item was judged. The results are shown in Tables 1 to 3. For stability, odor and coloration after 1 week were evaluated. Judgment is extremely good ・ ・ ・ ◎◎ Good ・ ・ ・ ・ ・ ・ ○ Somewhat unstable ・ ・ ・ ・ ・ ・ △ Unstable ・ ・ ・ ・ ・ ・ ・ ・It is indicated by x.
【0022】[0022]
【表1】 [Table 1]
【0023】[0023]
【表2】 [Table 2]
【0024】[0024]
【表3】 [Table 3]
【0025】表1〜3に示すように、本発明の皮膚外用
剤は、肌のうるおい、肌のハリ、翌朝の肌のうるおいに
優れかつ、安定性に優れたものであった。As shown in Tables 1 to 3, the external preparation for skin of the present invention was excellent in the moisture of the skin, the firmness of the skin, the moisture of the skin in the next morning, and the stability.
Claims (1)
なる群から選ばれる一種又は二種以上と、トレハロース
とを含有することを特徴とする皮膚外用剤。1. A skin external preparation containing one or more kinds selected from the group consisting of amino acids, amino acid derivatives and urea, and trehalose.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16208292A JPH06145037A (en) | 1992-05-28 | 1992-05-28 | Skin external preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16208292A JPH06145037A (en) | 1992-05-28 | 1992-05-28 | Skin external preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH06145037A true JPH06145037A (en) | 1994-05-24 |
Family
ID=15747747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16208292A Pending JPH06145037A (en) | 1992-05-28 | 1992-05-28 | Skin external preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH06145037A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0852949A3 (en) * | 1997-03-31 | 1999-08-04 | Shiseido Company Limited | Use of alpha-amino-acids for enhancing desmosomal degradation or stratum corneum desquamation |
| JP2007269692A (en) * | 2006-03-31 | 2007-10-18 | Pola Chem Ind Inc | Cosmetic material for softening skin |
| JP2011105665A (en) * | 2009-11-19 | 2011-06-02 | Kao Corp | Nonwoven fabric-impregnated cosmetic |
| JP5007417B2 (en) * | 2000-09-19 | 2012-08-22 | 株式会社林原 | Aggregate formation agent |
| JP2023084848A (en) * | 2021-12-08 | 2023-06-20 | 株式会社 資生堂 | Skin topical agent |
-
1992
- 1992-05-28 JP JP16208292A patent/JPH06145037A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0852949A3 (en) * | 1997-03-31 | 1999-08-04 | Shiseido Company Limited | Use of alpha-amino-acids for enhancing desmosomal degradation or stratum corneum desquamation |
| JP5007417B2 (en) * | 2000-09-19 | 2012-08-22 | 株式会社林原 | Aggregate formation agent |
| JP2007269692A (en) * | 2006-03-31 | 2007-10-18 | Pola Chem Ind Inc | Cosmetic material for softening skin |
| JP2011105665A (en) * | 2009-11-19 | 2011-06-02 | Kao Corp | Nonwoven fabric-impregnated cosmetic |
| JP2023084848A (en) * | 2021-12-08 | 2023-06-20 | 株式会社 資生堂 | Skin topical agent |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3503884B2 (en) | Cosmetics | |
| JP2018115181A (en) | External preparation composition with improved skin permeation | |
| JP2005314323A (en) | Hair growth formulation | |
| JPH0665049A (en) | External preparation for skin | |
| JP2002173449A (en) | Hair-growing agent | |
| JPH05221821A (en) | Skin-care cosmetic | |
| JPH09157172A (en) | Topical skin and eczema | |
| CA3085159A1 (en) | Topical compositions containing n-acyl dipeptide derivatives and glycolic acid | |
| JP3460904B2 (en) | External preparation for skin | |
| JP3784442B2 (en) | Topical skin preparation | |
| JPH06145037A (en) | Skin external preparation | |
| JP2004051521A (en) | Cosmetics containing dry cosmetic ingredients in non-woven fabric | |
| EP0204586A2 (en) | Stabilizer for hair compositions and such compositions | |
| JP5125122B2 (en) | Adapalene-containing external preparation composition | |
| JP5338030B2 (en) | Adapalene-containing external preparation composition | |
| JP5109383B2 (en) | Adapalene-containing external preparation composition | |
| JPH0892062A (en) | Topical | |
| JPS61227515A (en) | External preparation for skin | |
| JP3001121B2 (en) | External preparation for skin | |
| JP2620770B2 (en) | External preparation for skin | |
| JP5109382B2 (en) | Adapalene-containing external preparation composition | |
| JP5670008B2 (en) | Adapalene-containing external preparation composition | |
| JPH07215832A (en) | Skin external preparation | |
| JPH08259420A (en) | External composition for skin | |
| JP3516792B2 (en) | External preparation for skin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20010704 |